| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |